# OnCo record paper-swog-s1801-n-engl-j-med-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-swog-s1801-n-engl-j-med-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-swog-s1801-n-engl-j-med-2023" ;
  schema:name "Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma"@en ;
  schema:description "Published report from the SWOG S1801 trial registered as NCT03698019, in New England Journal of Medicine (2023), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-swog-s1801-n-engl-j-med-2023/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/nejmoa2211437>, <https://pubmed.ncbi.nlm.nih.gov/36856617/>, <https://europepmc.org/article/MED/36856617>, <https://clinicaltrials.gov/study/NCT03698019> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1056/nejmoa2211437> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Patel SP, Othus M, Chen Y, et al." ;
  onco:trials <https://onco.cc/trials/swog-s1801/> ;
  onco:journals <https://onco.cc/journals/nejm/> .